Delphi Ventures
Delphi Ventures was founded over 25 years ago as one of the first venture capital firms to focus on investing in life sciences companies.
Business Model:
Revenue: $16.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Delphi Ventures Information
Geographic Data
Address: 3000 Sand Hill Rd
City: Menlo Park
State: CA
Zip: 94025
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Delphi Ventures is a venture capital firm that has focused on investing in biotechnology and medical devices for over two decades. With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 110 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.
Contact Phone:
+16508549650
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2011 | Astute Medical | Series B | 13M |
| 6/2013 | ForSight VISION5 | Series B | 9.3M |
| 12/2007 | Barosense | Series C | 11.2M |
| 3/2006 | Breathe Technologies | Series A | 4M |
| 5/2010 | Breathe Technologies | Series C | 23M |
| 8/2001 | MicroVention Terumo | Series C | 12.5M |
| 2/2011 | EBR Systems | Series D | 5M |
| 5/2010 | Astute Medical | Series B | 26.5M |
| 10/2005 | PhotoThera | Series B | 19M |
| 8/2000 | Ican | Venture Round | 4M |
| 5/2011 | AEGEA Medical | Series B | 0 |
| 8/2000 | Ican | Venture Round | 4M |
| 1/2008 | Aragon Surgical | Series B | 25M |
| 6/2004 | Paracor Medical | Series C | 30.5M |
| 6/2007 | Paracor Medical | Series D | 44M |
| 1/2001 | Salmedix | Series A | - |
| 2/2009 | Primaeva Medical | Series C | 6M |
| 4/2000 | AmericasDoctor.com | Venture Round | 33.5M |
| 7/2013 | Karyopharm Therapeutics | Series B | 19M |
| 9/2014 | Ivantis | Series B | 25M |
| 4/2015 | EBR Systems | Venture Round | 20M |
| 3/2021 | Covalent | Venture Round | 0 |
| 3/2008 | Labcyte | Series C | 0 |
| 8/2007 | Vibrynt | Series A | 16M |
| 2/2000 | Agiliti | Series B | 0 |
| 5/2009 | PhotoThera | Series D | 50M |
| 9/2010 | Relypsa | Series B | 70M |
| 4/2006 | PhotoThera | Series C | 30.5M |
| 7/2012 | PTC Therapeutics | Private Equity Round | 30M |
| 9/2010 | NeurAxon | Debt Financing | 0 |
| 3/2021 | APWine | Seed Round | 0 |
| 5/2011 | Cameron Health | Series F | 107M |
| 4/2006 | SynergEyes | Series B | 0 |
| 7/2012 | Vifor Pharma | Private Equity Round | 0 |
| 8/2007 | NeurAxon | Series B | 32M |
| 8/2011 | Relypsa | Series B | 70.1M |
| 5/1999 | Xenogen Corporation | Series D | 11M |
| 11/2018 | LeddarTech | Convertible Note | 0 |
| 11/2002 | Alliance Medical Corporation | Series E | 7.3M |
| 9/2008 | Proteolix | Series C | 79M |
| 11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
| 7/2005 | Ilypsa | Series B | 36M |
| 4/2014 | Sequent Medical | Series D | 20M |
| 4/2000 | Digineer | Venture Round | 20M |
| 1/2004 | PTC Therapeutics | Series E | 35M |
| 12/2007 | Alder Biopharmaceuticals | Series C | 40M |
| 1/2018 | AEGEA Medical | Series D | 0 |
| 5/2006 | Eledon Pharmaceuticals | Series B | 35M |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 6/2011 | PolyRemedy | Series C | 20M |
| 8/2021 | Apricot Finance | Seed Round | 0 |
| 11/2011 | Pivot Medical | Series C | 32M |
| 6/2008 | EBR Systems | Series C | 35M |
| 7/2004 | LipoSonix | Series C | 27M |
| 1/2021 | Armor | Venture Round | - |
| 4/2015 | Cardeas Pharma | Series B | 37.5M |
| 3/2021 | Syndicate | Seed Round | 1M |
| 9/1999 | Alliance Medical Corporation | Series A | 8.5M |
| 6/2014 | Senseonics | Venture Round | 0 |
| 6/2010 | Anulex Technologies | Series E | 18.3M |
| 10/1999 | The Online Asset Exchange | Series A | 15.6M |
| 6/2009 | VytronUS | Series A | 11M |
| 3/2000 | GoToMyDoc | Venture Round | 25M |
| 4/2004 | NOVASYS MEDICAL | Series C | 25M |
| 9/2000 | Alliance Medical Corporation | Series B | 8M |
| 8/2012 | Vifor Pharma | Series C | 0 |
| 3/2007 | Phenomix | Series C | 55M |
| 11/2005 | PTC Therapeutics | Private Equity Round | 26.6M |
| 9/2001 | PTC Therapeutics | Series D | 0 |
| 1/2005 | Aragon Surgical | Series A | - |
| 5/2013 | Karyopharm Therapeutics | Series B | 48.2M |
| 6/2021 | Pontem Network | Venture Round | 0 |
| 6/2005 | Cierra | Funding Round | 21M |
| 12/2003 | KAI Pharmaceuticals | Series A | 17M |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 1/2008 | PixelOptics | Series B | 23.8M |
| 1/2013 | Ivantis | Series B | 27M |
| 9/2006 | PixelOptics | Series A | 8.4M |
| 3/2013 | PTC Therapeutics | Private Equity Round | 60M |
| 10/2008 | PixelOptics | Series C | 30M |
| 6/2004 | PTC Therapeutics | Series E | 0 |
| 12/2009 | PTC Therapeutics | Venture Round | 50M |
| 11/2007 | Evalve | Series D | 0 |
| 2/2007 | PTC Therapeutics | Series F | 10M |
| 3/2008 | TriVascular | Series A | 65M |
| 7/2006 | Anulex Technologies | Series C | 20M |
| 8/2007 | VytronUS | Series A | 6.6M |
| 7/2010 | Calithera Biosciences | Series A | 40M |
| 8/2009 | Barosense | Series D | 27M |
| 1/2022 | Friktion Labs | Venture Round | 0 |
| 5/2000 | Xenogen Corporation | Series E | 30.6M |
| 2/2022 | Jambo | Seed Round | 0 |
| 5/2022 | Jambo | Series A | 0 |
| 6/2012 | Astute Medical | Series C | 40.4M |
| 4/2023 | Karate Combat | Venture Round | 0 |
| 6/2012 | TriVascular | Series D | 60M |
| 5/2004 | Evalve | Series C | 0 |
| 5/2009 | Anulex Technologies | Series D | 10.2M |
| 8/2010 | TriVascular | Series C | 60M |
| 11/2009 | TriVascular | Series B | 30M |
| 4/2007 | Acclarent | Series C | 35M |
| 1/2005 | Alexza Pharmaceuticals | Series D | 0 |
| 1/2014 | Ivantis | Series B | 14M |
| 11/2011 | Calithera Biosciences | Venture Round | 4M |
| 2/2000 | Accordant Health Services | Venture Round | 14M |
| 6/2008 | Cameron Health | Series E | 0 |
| 4/2014 | ForSight VISION5 | Equity | 15M |
| 11/2013 | TriVascular | Series E | 0 |
| 3/2008 | Breathe Technologies | Series B | 15M |
| 6/2022 | Tatsumeeko | Seed Round | 0 |
| 5/2003 | TranS1 | Series B | 0 |
| 1/2002 | ActivBiotics | Series A | 17M |
| 3/2021 | XDEFI Wallet | Seed Round | 1.2M |
| 4/2007 | Reliant Technologies | Series E | 15M |
| 5/2023 | FastLane | Seed Round | 0 |
| 9/2021 | RECUR | Series A | 0 |
| 5/2008 | Novasys Medical, Inc. | Series D | 49.5M |
| 5/2008 | Novasys Health | Venture Round | 49.5M |
| 11/2003 | Cameron Health | Series B | 29M |
| 8/2010 | NeuroVista | Venture Round | 16.5M |
| 10/2007 | Vital Therapies | Series C | 28.1M |
| 6/2006 | Proteolix | Series B | 45M |
| 1/2006 | Primaeva Medical | Series A | 1.3M |
| 7/2006 | Cameron Health | Series D | 31M |
| 8/2021 | Chainflip | Seed Round | 0 |
| 6/2002 | Salmedix | Series B | 27.5M |
| 1/2009 | Acclarent | Venture Round | 26M |
| 4/2005 | Phenomix | Series B | 20M |
| 4/2014 | Sotera Wireless | Venture Round | 0 |
| 7/2003 | Refractec | Series D | 9M |
| 10/2007 | Relypsa | Series A | 33M |
| 4/2011 | PixelOptics | Series D | 45M |
| 7/2008 | ELENZA | Series A | 497k |
| 1/2001 | Labcyte | Series A | - |
| 10/2013 | Calithera Biosciences | Series D | 35M |
| 12/2006 | Primaeva Medical | Series B | 7M |
| 7/2014 | EBR Systems | Venture Round | 18.7M |
| 8/2000 | The Online Asset Exchange | Series B | 25M |
| 12/2012 | Calithera Biosciences | Series C | 2M |
| 9/2012 | Tandem Diabetes Care | Series D | 36.4M |
| 12/2008 | ELENZA | Series B | 6M |
| 2/2011 | ELENZA | Series B | 24M |
| 4/2003 | Arbor Surgical Technologies | Series A | 10.8M |
| 8/2021 | Fractional | Seed Round | 0 |
| 7/2002 | Barosense | Series A | 6.2M |
| 1/2010 | Tandem Diabetes Care | Series C | 53M |
| 3/2023 | Jungle | Seed Round | 0 |
| 7/2010 | BARRX Medical | Series D | 15M |
| 12/2009 | EBR Systems | Venture Round | 15M |
| 3/2008 | AEGEA Medical | Series A | 2.1M |
| 12/2004 | Barosense | Series B | 6.2M |
| 2/2009 | SynergEyes | Series C | 0 |
| 9/2001 | NOVASYS MEDICAL | Series B | 13M |
| 7/2006 | BARRX Medical | Series C | 27.8M |
| 1/2013 | Labcyte | Series D | 0 |
| 2/2007 | Proacta | Series B | 35M |
| 7/2002 | Labcyte | Series B | 22M |
| 3/2006 | Reliant Technologies | Series D | 22M |
| 2/2013 | Sotera Wireless | Series D | 0 |
| 5/2015 | AEGEA Medical | Series C | 0 |
| 4/2013 | Revance Therapeutics | Series E | 33M |
| 4/2012 | Alder Biopharmaceuticals | Series D | 0 |
| 5/2007 | NeuroVista | Series B | 33.8M |
| 6/2013 | ForSight Labs | Series B | 9.3M |
| 11/2001 | Locus Pharmaceuticals | Series C | 0 |
| 10/2008 | Lutonix | Series B | 20M |
| 8/2005 | Adiana | Series D | 23M |
| 3/2012 | Sequent Medical | Series C | 26M |
| 11/2000 | Locus Pharmaceuticals | Series B | 0 |
| 6/2022 | Tatsumeeko | Seed Round | 0 |
| 5/2022 | Jambo | Series A | 0 |
| 2/2022 | Jambo | Seed Round | 0 |
| 1/2022 | Friktion Labs | Venture Round | 0 |
| 9/2021 | RECUR | Series A | 0 |
| 8/2021 | Apricot Finance | Seed Round | 0 |
| 8/2021 | Fractional | Seed Round | 0 |
| 6/2021 | Pontem Network | Venture Round | 0 |
| 3/2021 | Covalent | Venture Round | 0 |
| 3/2021 | XDEFI Wallet | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
